A study in children with attention-deficit hyperactivity disorder (ADHD) suggests that genetic variability in the dopamine transporter gene (DAT1) influences the response to ADHD treatment.

From age 7 in girls and age 11 in boys in the UK, ADHD and obesity risk are linked, an association that likely begins around ages three to five.

Pharmacological treatment may reduce some types of criminality among adolescents and young adults with attention-deficit/hyperactivity disorder (ADHD), according to a study published online in the ...